Treatment of 2,453 acne vulgaris patients aged 12-17 years with the fixed-dose adapalene-benzoyl peroxide combination topical gel: Efficacy and safety

Journal of Drugs in Dermatology

Volumn 9, Issue 11, 2010, Pages 1395-1401

  Eichenfield, Lawrence F ^a   Jorizzo, Joseph L ^b   Dirschka, Thomas ^c   Taub, Amy Forman ^d   Lynde, Charles ^e   Graeber, Michael ^f   Kerrouche, Nabil ^g  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b WAKE FOREST UNIVERSITY   (United States)

^c UNIVERSITY OF WITTEN HERDECKE   (Germany)

^d Advanced Dermatology   (United States)

^e Lynderm Clinical Research   (Canada)

^f Galderma Research and Development   (United States)

^g Galderma R and D   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPALENE PLUS BENZOYL PEROXIDE; ADAPALENE; BENZOYL PEROXIDE; CHLORMETHINE; DERMATOLOGICAL AGENT; NAPHTHALENE DERIVATIVE;

ACNE VULGARIS; ADOLESCENT; APPLICATION SITE BURNING; APPLICATION SITE DRYNESS; ARTICLE; CHILD; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ERYTHEMA; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SCORING SYSTEM; TREATMENT OUTCOME; DRUG COMBINATION; GEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); TOPICAL DRUG ADMINISTRATION;

ACNE VULGARIS; ADMINISTRATION, TOPICAL; ADOLESCENT; BENZOYL PEROXIDE; CHILD; DERMATOLOGIC AGENTS; DRUG COMBINATIONS; FEMALE; GELS; HUMANS; MALE; MECHLORETHAMINE; NAPHTHALENES; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 79952112476     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Rademaker M, Garioch JJ, Simpson NB. Acne in school children: No longer a concern for dermatologists. Br Med J. 1989;298:1217-1219. (Pubitemid 19122792)
2. Smithard A, Glazebrook C, Williams HC. Acne prevalence, knowledge about acne and psychological morbidity in mid-adolescence: A community-based study. Br J Dermatol. 2001;145:274-279. (Pubitemid 32955354)
3. Mallon E, Newton JN, Klassen A et al. The quality of life in acne: A comparison with general medical conditions using generic questionnaires. Br J Dermatol. 1999;140:672-676. (Pubitemid 29191387)
4. Mulder MM. Psychological impact of acne vulgaris. Dermatology. 2001;203:124-130.
5. Tan JK. Psychosocial impact of acne vulgaris: Evaluating the evidence. Skin Ther Lett. 2004;9:1-3.
6. Aktan S, Ozmen E, Sanli B. Anxiety, depression, and nature of acne vulgaris in adolescents. Int J Dermatol. 2000;39:354-357. (Pubitemid 30335781)
7. Gollnick H, Cunliffe W, Berson D, et al. Management of acne: A report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2003;49(Suppl 1):1-37.
8. Thiboutot D, Gollnick H, Bettoli V, et al. New insights into the management of acne: An update from the Global Alliance to Improve Outcomes in Acne Group. J Am Acad Dermatol. 2009;60(Suppl 5):S1-S50.
9. Leyden JJ. A review of the use of combination therapies for the treatment of acne vulgaris. J Am Acad Dermatol. 2003;49(Suppl 3):200-210.
10. Layton AM, Eady EA. Benzoyl peroxide and adapalene fixed combination: A novel agent for acne. Br J Dermatol. 2009;16:971-976.
11. Tan JKL. Adapalene 0.1% and benzoyl peroxide 2.5%: A novel combination for the treatment of acne vulgaris. Skin Ther Lett. 2009;14:4-5.
12. Millikan LE. The rationale for using a topical retinoid for inflammatory acne. J Am Clin Dermatol. 2003;4:75-80. (Pubitemid 36259516)
13. Kligman AM. Acne vulgaris: Tricks and treatments. Part II: The benzoyl peroxide saga. Cutis. 1995;56:260-261.
14. Thiboutot DM, Weiss J, Bucko A, et al. Adapalene-benzoyl peroxide, a fixed dose combination for the treatment of acne vulgaris: Results of a multicenter, randomised double-blind, controlled study. J Am Acad Dermatol. 2007;57:791-799. (Pubitemid 47553072)
15. Gold LS, Tan J, Cruz-Santana A et al. A North American study of adapalene-benzoyl peroxide combination gel in the treatment of acne. Cutis. 2009; 84:110-116.
16. Gollnick HPM, Draelos Z, Glenn MJ, et al. Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: A transatlantic, randomized, double-blind, controlled study in 1670 patients. Br J Dermatol. 2009;161:1180-1189.
17. Tan J, Gollnick H, Stein Gold L, et al. Synergistic efficacy of adapalene 0.1%-benzoyl peroxide 2.5% in the treatment of 3855 acne vulgaris patients. J Dermatol Treat. 2010 Jul 28 [Epub ahead of print.]
18. Gollnick HP, Finlay AY, Shear N. Can we define acne as a chronic disease? If so, how and when? J Am Clin Dermatol. 2008;9:279-284.
19. Raimer S, Maloney JM, Bourcier M, et al. Efficacy and safety of Dapsone gel 5% for the treatment of acne vulgaris in adolescents. Cutis. 2008;81:171-178.
20. Jorizzo J, Grossman R, Nighland M. Tretinoin microsphere gel in younger acne patients. J Drugs Dermatol. 2008;7:S9-S13.
21. Eichenfield LF, Wortzman M. A novel gel formulation of 0.25% tretinoin and 1.2% clindamycin phosphate: Efficacy in acne vulgaris patients aged 12-18 years. Pediatr Dermatol. 2009;26:257-261.
22. Pariser DM, Westmoreland P, Morris A, et al. Long-term safety and efficacy of a unique fixed-dose combination gel of adapalene 0.1% and benzoyl peroxide 2.5% for the treatment of acne vulgaris. J Drugs Dermatol. 2007;6:899-905.
23. World Health Organization. WHO Global Strategy for Containment of Antimicrobial Resistance. 2001. Available at http://www.who.int/csr/resources/ publications/drugresist/WHO-CDS-CSR-DRS-2001-2-EN/en/. Accessed 28 September 2009.
24. Thiboutot D, Dreno B, Layton A. Acne counselling to improve adherence. Cutis. 2008;81:81-86.
25. Dreno B, Thiboutot D, Gollnick H, et al. Large-scale worldwide observational study of adherence with acne therapy. Int J Dermatol. 2010;49(4):448-456.